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It is well established that natural killer (NK) cells
confer resistance to many viral diseases, but in only
a few instances the molecular mechanisms whereby
NK cells recognize virus-infected cells are known.
Here we show that CD94, a molecule preferentially
expressed by NK cells, is essential for the resistance
of C57BL/6 mice to mousepox, a disease caused by
theOrthopoxvirus ectromelia virus. Ectromelia virus-
infected cells expressing the major histocompati-
bility complex (MHC) class Ib molecule Qa-1b are
specifically recognized by the activating receptor
formed by CD94 and NKG2E. Because CD94-NKG2
receptors and their ligands are highly conserved in
rodents and humans, a similar mechanism may exist
during human infections with the smallpox and mon-
keypox viruses, which are highly homologous to
ectromelia virus.
INTRODUCTION
Natural killer (NK) cells play important roles in protection from
several, but not all, viral diseases (Lanier, 2008a; Lee and Biron,
2010). During some but not all viral infections, NK cells are
activated and induced to proliferate by innate cytokines (Lee
and Biron, 2010). Their ability to kill infected cells and protect
from viral disease appears to require the interaction of specific
activating receptors on the NK cells with ligands at the surface
of infected cells (Lee and Biron, 2010). To date, only a few NK
cell receptor-ligand interactions important for resistance to viral
diseases have been characterized. The best studied involves the
resistance to mouse cytomegalovirus (MCMV) infection by
C57BL/6 (B6) mice where the activating receptor Ly49H specif-
ically recognizes the viral protein m157 (Arase et al., 2002;
Daniels et al., 2001; Smith et al., 2002) and by MA/My mice
where the activating receptor Ly49P recognizes the major
histocompatibility complex (MHC) class I molecule H2-Dk in
complex with the viral protein m04 (Kielczewska et al., 2009).
These mechanisms, however, are not conserved in humans
because humans do not encode homologs of Ly49 molecules
and because MCMV is fairly different from human cytomegalo-virus (HCMV). Another less-well-characterized mechanism is
the recognition of the influenza hemagglutinin by NKp46 on
human and mouse NK cells (Gazit et al., 2006; Mandelboim
et al., 2001).
Mousepox is a viral disease where an essential role for NK
cells is well established (Delano and Brownstein, 1995; Fang
et al., 2008; Jacoby et al., 1989; Parker et al., 2007). Mousepox
is caused by the mouse Orthopoxvirus (OPV) ectromelia virus
(ECTV), a close relative of the human pathogens variola virus
(VARV, the agent of smallpox) and monkeypox virus (MPXV),
which causes monkeypox, a grave endemic disease in central
Africa that has recently caused an outbreak in the USA (Gross,
2003; Larkin, 2003). Young adult B6 mice are naturally resistant
to mousepox when infected through the skin of the footpad, the
natural route of infection. To understand the genetic mecha-
nisms involved in mousepox resistance, Brownstein et al.
(1991) infected a panel of B63DBA2/J recombinant inbred
strains of mice and determined virus titers in the liver after i.v.
infection with ECTV. This resulted in the mapping of four genes
involved in the B6 mice resistance to mousepox (Rmp1–
Rmp4). Rmp1 resides in the natural killer (NK) complex (NKC)
(Delano andBrownstein, 1995), a polymorphic region in the distal
arm of chromosome 6 that varies widely among different strains
of mice and encodes most of the inhibitory and activating recep-
tors preferentially expressed by NK cells (Brown and Scalzo,
2008; Yokoyama et al., 1991). However, the identity of Rmp1
remains elusive. Moreover, the extent to which Rmp1 contrib-
utes to disease and lethality after footpad infection remains
unknown.
NKG2D is an NK cell activating receptor that forms homo-
dimers that bind host cell-encoded MHC class I-like proteins
expressed by target cells. We have previously shown that
NKG2D contributes to NK cell-mediated resistance to mouse-
pox by providing optimal ability to kill targets expressing
NKG2D ligands (Fang et al., 2008). However, our data also sug-
gested that in addition to NKG2D, other activating receptors
expressed by NK cells may also be essential for resistance
(Fang et al., 2008).
CD94 is a NKC-encoded molecule that forms heterodimeric
receptors with NKC-encoded NKG2A, -C, and -E in the mouse
and NKG2A, -C, and -E in humans. Despite their name and close
linkage, these NKG2s are structurally and functionally unrelated
to NKG2D and NKG2D does not pair with CD94 (Lanier, 2005).
In rodents and primates, CD94-NKG2 heterodimers bind MHC
class Ib molecules (Qa-1b in mice, HLA-E in humans) at theImmunity 34, 579–589, April 22, 2011 ª2011 Elsevier Inc. 579
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Figure 1. The Natural Killer Complex from DBA/2J Mice Renders B6
Mice Susceptible to Mousepox
(A) B6 and B6.D2-D6 mice were infected with ECTV and survival was moni-
tored.
(B) Virus titers in spleen and liver 7 dpi (gray columns, B6 mice; white columns,
B6.D2-D6 mice).
Data correspond to the average ± SD of three individual mice.
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CD94 Is Essential for Resistance to Mousepoxsurface of cells. The CD94-NKG2A receptor is inhibitory and is
the first MHC class I-binding receptor expressed during NK
cell development, but its expression is dispensable for the
normal differentiation of NK cells (Orr et al., 2010). CD94-
NKG2C and CD94-NKG2E receptors are activating, but
a specific role in NK cell biology remains to be described. The
work presented here demonstrates that CD94 is essential for
the resistance of B6 mice to mousepox. We also show that
CD94 together with NKG2E recognizes ECTV-infected cells
that express Qa-1b and that effective signaling requires
NKG2D costimulation. This suggests that NK cells use a molec-
ular mechanism reminiscent of T cell recognition to selectively
target poxvirus-infected cells.RESULTS
The Natural Killer Complex from DBA2/J Mice Render
B6 Mice Susceptible to Mousepox
To characterize the role of the NKC in resistance to mousepox,
we performed footpad infection of B6.D2-(D6Mit149-D6Mit15)/
LusJ (herein B6.D2-D6) mice, a C57BL/6 congenic strain
carrying the distal portion of chromosome 6, including the
NKC, from DBA/2J mice (Davis et al., 2005). We found thatLo
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580 Immunity 34, 579–589, April 22, 2011 ª2011 Elsevier Inc.B6.D2-D6 mice were highly susceptible to mousepox: the vast
majority succumbed to infection (Figure 1A) and demonstrated
very high virus loads in liver and spleen 7 days postinfection
(dpi) (Figure 1B). These data showed that the DBA/2J NKC is
sufficient to render B6 mice susceptible to mousepox after
footpad inoculation but did not indicate which genes within the
B6 NKC confer resistance. It is relevant to mention, however,
that our data do not indicate that genes within the NKC are
uniquely responsible for the susceptibility of DBA2/J mice or
other susceptible strains to mousepox. In fact, three additional
genes (Rmp2–4), not in the NKC, have been mapped in DBA2/
J mice (Brownstein et al., 1991).B6 Congenic Mice Deficient in CD94 Are Susceptible
to Mousepox
CD94 is a molecule expressed by NK cells and some activated
T cells, NKT cells, and gd T cells. It is encoded by Klrd1 within
the NKC and forms inhibitory receptors with NKG2A and acti-
vating receptors with NKG2C and NKG2E, which are structurally
and functionally unrelated to NKG2D (Lanier, 2005). Although it
has been shown that fibroblasts infected with HCMV can drive
preferential proliferation of human NK cells expressing CD94-
NKG2C in vitro (Guma´ et al., 2006), a specific role for CD94-
NKG2 in controlling viral diseases has never been established.
It has previously been reported that the parental DBA/2 mouse
strain expresses CD94 on NK cells but that the DBA/2J substrain
does not (Vance et al., 2002). Consistent with this observation,
NK cells from B6.D2-D6 mice (with the NKC from DBA/2J) did
not express CD94. Furthermore, because cell surface expres-
sion of NKG2A, NKG2C, and NKG2E requires CD94, B6.D2-D6
mice did not express any of these molecules at the surface of
their NK cells (Figure 2A). This raised the enticing possibility
that CD94-NKG2 receptors might be essential for resistance to
mousepox. Arguing against this hypothesis, however, DBA/2
mice (the parental strain of DBA/2J) are also susceptible to
mousepox even though they do express CD94. This could be
due to Rmp2–Rmp4 or other unidentified genes in the DBA/2
background. To clarify this issue, we infected B6 mice that ex-
pressed the 129 strain NKC with a targeted deletion of Klrd1
(Klrd1/, CD94-deficient) (Orr et al., 2010) and found that they
were also very susceptible to mousepox, as indicated by highSpleen Liver
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Figure 2. B6 Congenic Mice Deficient in
CD94 Are Susceptible to Mousepox
(A) Flow cytometry analysis of white blood cells in
B6.D2-D6 mice. Top: Gated on lymphocytes ac-
cording to forward angle (FSC) and side angle
(SSC) light scattering properties. Staining for
NKp46 and CD3 is shown. Bottom: gated on
NKp46+CD3 (NK) cells as indicated in the upper
plots. Staining for CD94 and NKG2 is shown.
(B) Wild-type B6, CD69-deficient, and CD94-defi-
cient mice were infected with ECTV and survival
was monitored. p value for wild-type B6 or CD69-
deficient versus CD94-deficient mice.
(C) Virus titers in spleen and liver 7 dpi (gray
columns, B6 mice; white columns, CD94-deficient
mice).
Data correspond to the average ± SD of six indi-
vidual mice from two independent experiments.
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Figure 3. CD94 Is Essential for Resistance to Mousepox
(A) Wild-type B6 or [B6.D2-D6 3 CD94-deficient] F1 mice were infected with ECTV and survival was monitored.
(B) CD94 transgenic (Tg+) and nontransgenic (Tg) CD94-deficient3 [CD94-deficient3 B6-CD94Tg] F1 littermate mice and parental CD94-deficient mice were
infected with ECTV and survival was monitored.
(C) Transgenic (Tg+) and nontransgenic (Tg) B6.D2-D63 [B6.D2-D63B6-CD94Tg] F1 littermatemice and parental B6.D2-D6micewere infectedwith ECTV and
survival was monitored.
(D) Flow cytometric analysis of white blood cells from the indicated mice. Plots are gated on NKp46+CD3 NK cells. Staining for CD94 and NKG2 is shown.
Data are representative of three similar experiments.
(E) B6 mice were treated with 150 mg 20D5HCmIgG1-Q mAb or an isotype-matched control mAb, infected with ECTV and survival monitored.
Data are cumulative from three independent experiments.
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CD94 Is Essential for Resistance to Mousepoxmortality (Figure 2B). Of note, the susceptibility of CD94-defi-
cient mice to mousepox is not a general defect of the strain to
resist viral infections; they control the highly related vaccinia
virus (VACV) and lymphocytic choriomeningitis virus as effi-
ciently as do wild-type (WT) B6 controls (Orr et al., 2010). It
should be noted, however, that although CD94-deficient mice
were backcrossed to the B6 background for at least nine gener-
ations, they still carry the NKC from the original 129 strain
(Orr et al., 2010). Nonetheless, similarly to B6 mice, 129 mice
are naturally resistant to mousepox and NK cells are essential
for their resistance (Fang et al., 2008), strongly suggesting that
the 129 NKC does not confer susceptibility to mousepox. In
support of this, B6 mice that express the 129 strain NKC with
a targeted deletion of Cd69 (Murata et al., 2003), but possessing
a functionalKlrd1 gene of 129 origin, were resistant tomousepox
(Figure 2B). Consistent with their susceptibility to lethal mouse-
pox infection, CD94-deficient mice had significantly higher viral
loads in spleen and liver 7 dpi as compared with wild-type B6
mice (Figure 2C).CD94 Is Essential for Resistance to Mousepox
We performed additional experiments to conclusively establish
an essential role for CD94 in resistance to mousepox. First, we
found that [B6.D2-D6 3 CD94-deficient] F1 mice were also
susceptible to mousepox (Figure 3A), demonstrating that
B6.D2-D6 and CD94-deficient genotypes did not complement
each other. This strongly suggested that the reason for the
susceptibility of both strains is the same, i.e., loss of CD94.
Second, klrd1 expressed as a transgene (Tg+) (Orr et al., 2010)
restored resistance to mousepox in CD94-deficient mice (Fig-
ure 3B) and B6.D2-D6 mice (Figure 3C), whereas Tg littermatesremained as susceptible as the original CD94-deficient strains.
As expected, the klrd1 transgene rescued NKG2 expression in
CD94-deficient mice (Figure 3D) and B6.D2-D6 mice (not
shown). Third, treatment of mice with 20D5HCmIgG1-Q, which
is a monoclonal antibody that blocks ligand binding by the
CD94-NKG2 receptors but without depleting NK cells in vivo
(Figure S1 available online; Orr et al., 2010), resulted in significant
lethality in ECTV-infected wild-type B6 mice (Figure 3E).
Although antibody treatment did not result in lethality in all of
the infected mice, most probably because of incomplete
in vivo blockade, the data reinforce the notion of a direct role
for CD94-NKG2 receptors in mousepox resistance, rather than
a developmental defect of NK cells in the B6.D2-D6 and CD94-
deficient strains.NK Cells Require CD94 to Protect from Mousepox
but Not to Migrate to the Draining Lymph Nodes
We have previously shown that 2–3 days after ECTV infection in
the footpad, activated NK cells are recruited to the draining
popliteal lymph node (D-LN) where they produce IFN-g and
presumably kill infected cells (Fang et al., 2008). The recruitment
of NK cells and the activation of their effector functions are
essential to curb early systemic virus spread. Depletion of NK
cells or their inability to produce IFN-g or perforin (Fang et al.,
2008) or their inefficient migration to the D-LN resulting from
age (Fang et al., 2010) results in increased virus titers in the liver
starting 3 dpi (a time point at which T cells are not yet involved in
virus control) with the consequence of lethal mousepox infection
(Fang et al., 2008). Similarly, absence of CD94 in the B6.D2-D6
mice (Figure 4A), CD94-deficient mice (Figure 4B), and antibody
blockade of CD94-NKG2 in wild-type B6 mice (Figure 4C), allImmunity 34, 579–589, April 22, 2011 ª2011 Elsevier Inc. 581
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Figure 4. Lack of CD94 Results in Defective NK Cell Control of ECTV Spread
(A) B6 mice (gray columns) and B6.D2-D6 mice (white columns) were infected with ECTV, and virus titers in spleen and liver were determined 3 dpi. Data
correspond to the average ± SD of five individual mice and are representative of two similar experiments.
(B) Wild-type B6 mice or CD94-deficient mice were depleted or not of NK cells with 15 ml anti-Asialo GM antibody and infected with ECTV. Virus titers in spleen
(gray bars) and liver (white bars) were determined 3 dpi. Data correspond to the average ± SD of five individual mice from two independent experiments.
(C) Wild-type B6 mice treated with blocking 20D5HCmIgG1-Q mAb (gray columns) or an isotype-matched control mAb (white columns) were infected with ECTV
and virus titers determined 3 dpi. Data correspond to the average ± SD of six individual mice from two independent experiments.
(D) Wild-type and CD94-deficient B6 mice were infected with ECTV. NK cell proliferation was determined 5 dpi in the spleen by BrdU incorporation. Bar graph is
the cumulative data for three similar experiments with threemice/group. Representative flow cytometry plots of gated DX5+CD3NK cells are shown on the right.
Immunity
CD94 Is Essential for Resistance to Mousepox
582 Immunity 34, 579–589, April 22, 2011 ª2011 Elsevier Inc.
Immunity
CD94 Is Essential for Resistance to Mousepoxresulted in increased virus loads in the liver 3 dpi, indicating an
NK cell defect. Moreover, depletion of NK cells in B6 mice with
Asialo GM1 antibody increased virus loads in the liver and spleen
3 dpi to titers similar to those in CD94-deficient mice, whereas
NK cell depletion in CD94-deficient mice did not further increase
virus loads (Figure 4B). In addition, we have previously shown
extensive proliferation of NK cells in the spleen of ECTV-infected
B6 mice 5 dpi (Fang et al., 2008). Consistent with defective NK
cell response in the absence of CD94, NK cell proliferation
5 dpi was significantly reduced in the spleens of CD94-deficient
mice as compared with wild-type B6 mice (Figure 4D). However,
CD94-deficient mice did not differ from wild-type B6 mice in the
recruitment of NK cells to the D-LN (Figure 4E) or their activation,
as determined by the expression of the effector molecules IFN-g
and granzyme B (GzB) (Figure 4F), which are essential for NK
cells to protect from mousepox (Fang et al., 2008). Similar acti-
vation and recruitment of NK cells to the D-LN were also seen
in B6.D2-D6 mice and in other mousepox-susceptible strains
such as BALB/c and DBA2/J (not shown). Together these results
suggest that CD94 deficiency does not prevent the migration of
NK cells to the D-LN or their activation (which is probably due to
cytokines) but might specifically affect their ability to kill virus-
infected target cells. The ligand for CD94-NKG2 heterodimers
is the class Ib MHC I molecule Qa-1b, which is encoded by the
H2-T23 gene (Vance et al., 1999). Of interest, similar to CD94-
deficient mice, Qa-1b-deficient B6 mice (H2-T23/, which
express CD94-NKG2 receptors and the entire B6 NKC) exhibited
significantly higher virus titers in liver and spleen 3 dpi as
compared to WT B6 mice and, different from WT B6 mice, NK
cell depletion did not result in an additional increase in virus
loads in Qa-1b mice (Figure 4G). This suggested that NK cells
may use CD94-NKG2s to recognize Qa-1b on ECTV-infected
cells. It should be mentioned, however, that only 20% of
Qa-1b-deficient mice succumbed to mousepox (not shown).
Still, it is very possible that other mechanisms can compensate
the NK cell deficiency in Qa-1b-deficient mice, allowing substan-
tial survival despite initial high virus loads. For example, it has
been shown that Qa-1b-deficient mice lack CD8+ regulatory
T cells and this may result in enhanced effector CD8+ T cell
activity (Hu et al., 2004; Lu et al., 2006).Deficient NK Cell Control of Virus Loads in the Absence
of CD94 Results in a Defective CD8+ T Cell Response
Although expressed predominantly by NK cells, CD94 is also ex-
pressed by some activated CD8+ T cells. The death of B6.D2-D6
andCD94-deficient mice at approximately 10 dpi was consistent
not only with defective NK cell function, but also with defective
CD8+ T cell responses (Fang and Sigal, 2006). Thus, we analyzed
the ECTV-specific CD8+ T cell responses in CD94-deficient mice
(Figure S2A) and B6.D2-D6mice (not shown). We found that they(E)Wild-type B6 and CD94-deficient mice were infected with ECTV or not and the
the cumulative data for five independent experiments as a column graph and rep
lymphocytes as determined by FSC and SSC.
(F) Column graphs show the cumulative data for GzB- and IFN-g-positive cell
Representative flow cytometry plots as used for the columns graphs are shown
(G) B6 Wild-type or Qa-1b-deficient B6 mice depleted or not of NK cells with NK
spleen were determined 3 dpi. Data correspond to the mean ± SD of five mice (bwere highly deficient, as evidenced by decreased frequencies of
CD8+ T cells expressing GzB and IFN-g after ex vivo restimula-
tion with infected cells and also after staining with H2-Kb-dimers
loaded with TSYKFESV, the most immunodominant ECTV CD8
T cell determinant (Tscharke et al., 2005). However, as it occurs
with aged B6 mice (Fang et al., 2010) or after NK cell depletion
(Fang et al., 2008), the defective CD8+ T cell response was not
CD8+ T cell intrinsic because the CD8+ T cell responses of
wild-type B6 and CD94-deficient mice were similarly strong
when infected with vaccinia virus, an OPV that is poorly patho-
genic in mice but shares most of the CD8+ T cell determinants
with ECTV, including TSYKFESV (Figure S2B). Moreover,
CD94-deficient CD8+ T cells responded as efficiently as did
CD94-sufficient CD8+ T cells in a CD94-sufficient environment
(Figure S2C), while CD94-sufficient CD8+ T cells responded as
poorly as did CD94-deficient CD8+ T cells in a CD94-deficient
environment (Figure S2C) as determined by proliferation and
H2-Kb-TSYKFESV dimer staining after adoptive transfer of
T cells. Moreover, adoptive transfer of memory CD8+ T cells
obtained from CD94-deficient mice immunized with VACV pro-
tected naive CD94-deficient mice from mousepox (Figure S2D).
Together, our studies of the CD8+ T cell response show that the
defective CD8+ T cell response and susceptibility of CD94-defi-
cient mice tomousepox were due to a defect in the ability of their
NK cells to control early virus spread and not to intrinsically
defective CD8+ T cells.CD94-NKG2E Recognizes ECTV-Infected Cells in the
Presence of NKG2D and in a Qa-1b-Dependent Manner
CD94-NKG2A receptors are inhibitory whereas CD94-NKG2C
and CD94-NKG2E are activating (Lanier, 2008b). When we
compared the D-LN of uninfected and infected (2 dpi) B6 mice,
we found that in the infected mice there was a decrease in the
proportion (Figure 5A) and mean fluorescence intensity (Fig-
ure 5B) of cells that stained with the NKG2A mAb 16A11 but
not with the NKG2 (i.e., recognizing NKG2A, NKG2C, and
NKG2E) mAb 20D5. This suggested an increase in the expres-
sion of activating NKG2s and a decrease of inhibitory NKG2A
at the surface of NK cells in the D-LN. We were unable to directly
test this possibility at the protein level because Abs specific for
NKG2C and E are not available. This was important to confirm,
however, because it is known that mouse splenic NK cells
express very low amounts of activating NKG2s (Vance et al.,
1999, 2002). Therefore, we performed quantitative polymerase
chain reaction (qPCR) after reverse transcription for NKG2E.
NKG2E transcripts were detected in the NK cell fraction but
not in the NK cell-depleted fraction of LNs after magnetic sorting,
confirming some expression in the NK cells of naive mice (Fig-
ure 5C). It should be noted, however, that the signal for NKG2E
was weaker than that obtained with primers for NKG2A (notdraining popliteal lymph nodewas analyzed by flow cytometry 2 dpi. Shown are
resentative plots indicating the proportion of NK cells (DX5+, CD3) gated on
s in the DX5+CD3 NK cell gate (from D) for five independent experiments.
on the right.
1.1 mAb treatment were infected with ECTV and the virus titers in the liver and
ars as indicated).
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Figure 5. Upregulation of NKG2E and Qa-1b during ECTV Infection
(A) Wild-type B6 mice were infected with ECTV in the footpad or not and the
expression of NKG2A and NKG2 in the draining popliteal lymph node was
determined. Flow cytometry plots correspond to pools of LNs from three mice
and are representative of two similar experiments. Data show cells gated on
NK1.1+CD3 NK cells.
(B) As in (A) but showing histograms to highlight changes inmean fluorescence
intensities (shaded histogram, uninfected mice; black line, infected mice). The
numbers indicate the mean fluorescence intensity of the closest histogram.
(C) LN cells were magnetically sorted into DX5+ (NK cells, 40% pure) and DX5
(non-NK, >99% pure). RNA was isolated, reverse transcribed, and the NKG2E
message was quantified by qPCR with a specific primers/probe set. Data
correspond to themean ± SD of two wells and are representative of two similar
experiments.
(D) RNA was obtained from the LNs of the indicated mice and analyzed by
qPCR as in (C). Data correspond to the mean ± SD of two wells and are
representative of two similar experiments.
(E) L cells were infected for 4 hr with 1 PFU/cell of sucrose-purified ECTV virus.
Surface expression of Qa-1 was analyzed by flow cytometry. Data are repre-
sentative from three similar experiments (shaded gray, isotype-matched
control Ig; thin line, anti-Qa-1 staining of uninfected L cells; thick line, anti-Qa-1
staining of infected L cells).
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higher levels than activating NKG2E. Still, 2 and 3 dpi NKG2E
transcripts were increased 16- and 20-fold in the D-LN, respec-
tively, as compared to the LN of uninfected mice while little
changewas observed in the ND-LN (Figure 5D). The qPCR assay
was specific because it generated amplicons when using
a plasmid encoding for NKG2E but not NKG2A or NKG2C as
the template. Thus, we conclude that low levels of NKG2E
were expressed in NK cells and that expression increased in
the D-LN after ECTV infection. Because the fold increase in tran-
scripts is higher than the fold increase of NK cells in the D-LN, the
data suggest upregulation of NKG2E by NK cells after infection.
In vitro infection of mouse L cells with ECTV upregulated the
expression of the Qa-1b glycoprotein (Figure 5E), further sug-
gesting that NK cells might recognize ECTV-infected cells via
activating NKG2s in a Qa-1b-dependent manner. To test for
these possibilities, we generated reporter cell lines expressing
green fluorescence protein (GFP) controlled by an NFAT
promoter (NFAT-GFP) the signaling adaptor DAP12, CD94, and
either activating NKG2C or NKG2E. Based on our prior studies
implicating NKG2D in resistance to mousepox (Fang et al.,
2008), we also cotransduced these reporter cells with the short
form of NKG2D (NKG2D-s) that can pair and signal with
DAP12. Expression of CD94, NKG2D, NKG2C, and NKG2E
was verified on the cell surface of the reporter cell lines by flow
cytometry (Figure S3). We found that the reporter cells express-
ing CD94, NKG2E, and NKG2D-s significantly increased GFP
expression when coincubated with ECTV-infected as compared
to uninfected L cells. None of the other reporters were signifi-
cantly activated by ECTV-infected L cells, including those that
expressed CD94 and NKG2E, with DAP12, in the absence of
NKG2D-s (Figure 6A). The activation of the CD94+NKG2E+
NKG2D+ reporter by ECTV-infected L cells wasCD94 dependent
because it was inhibited by a blocking CD94mAb but not an iso-
type-matched Ig control (Figure 6B). Further, the CD94+NKG2E+
NKG2D+ reporters responded to human 293T cells transfected
with mouse Qa-1b and infected with ECTV, but much less to
uninfected 293T cell transfected with Qa-1b or to 293T cells
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Figure 6. CD94-NKG2E, but Not CD94-NKG2C, Recognizes ECTV-Infected Cells in the Presence of NKG2D and in a Qa-1b-Dependent
Manner
(A) L cells were infected with 1 PFU/cell purified ECTV virus for 2 hr, washed, and coincubated with the indicated reporters for 18 hr at 37C. The expression of
GFP by the reporters was then analyzed by flow cytometry, gating on the reporter cells as distinguished by forward angle light scatter and side angle light scatter
properties. Top histograms are representative data (shaded gray, reporter cells with uninfected L cells; dotted thick line, reporter cells with ECTV-infected L cells).
The bottom panel displays the results for 2–5 individual experiments where the y axis is the ratio of the geometric mean of the GFP fluorescence for the indicated
reporter cells incubated with infected or uninfected L cells.
(B and C) L cells (B) and 293T cells (B) were treated as indicated or kept uninfected and incubated with CD94+NKG2E+NKG2D+ reporters for 16 hr, and the
reporters’ GFP fluorescence was determined by flow cytometry. Data represent the ratio of the geometric mean of the reporter cells incubated with L cells (B) or
293T cells (C) treated as indicated/GFP fluorescence of the reporter cells incubated with uninfected L cells. Data are representative of three similar experiments.
(D) Splenocytes from wild-type B6 mice were incubated for 5 hr with the indicated bound mAbs in the presence of 1000 U IL-2. Cells were analyzed by flow
cytometry. Data show the proportion of NK cells (NK1.1+CD3) that expressed intracellular IFN-g. Data correspond to the mean ± SD of three replicate samples
and are representative of two similar experiments.
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Together, these results strongly suggest that NKG2D and
CD94-NKG2E (but not CD94-NKG2C) synergize to recognize
ECTV-infected cells in a Qa-1b-restricted manner.
The synergy between the NKG2D and activating CD94-NKG2
receptors in NK cell activation was further explored in assays
where splenocytes from naive mice were incubated for 5 hrwith plate-immobilized mAbs and the NK cells analyzed by
flow cytometry for intracellular IFN-g production. The results
showed that CX5 (anti-NKG2D) and 20D5 (anti-NKG2) induced
IFN-g production in NK cells and that the proportion of NK cells
producing IFN-g was further increased when CX5 and 20D5
were combined. On the other hand, 16A11 (anti-NKG2AB6) did
not induce IFN-g production and the induction of IFN-gImmunity 34, 579–589, April 22, 2011 ª2011 Elsevier Inc. 585
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combined with 16A11 (Figure 6D). Together, these experiments
demonstrate a synergy between NKG2D and the activating
CD94-NKG2 receptors in primary splenic NK cells and function-
ally demonstrate activating CD94-NKG2 receptor expression at
the surface of primary NK cells. Further, because 20D5 binds
activating NKG2s as well as inhibitory NKG2A, these results
may indicate the existence of a subset of NK cells expressing
activating CD94-NKG2C or E receptors in the absence of
NKG2A expression.
DISCUSSION
Here we demonstrated that the NK cell receptor CD94 has an
essential role in the resistance of B6 mice to mousepox, adding
to the still very limited number of NK cell receptors with known
function in protecting from viral diseases. The susceptibility of
CD94-deficient mice to mousepox was observed in B6 strains
carrying the NKC haplotypes from the mousepox-susceptible
DBA2/J strain with a spontaneous mutation in Klrd1 or from
the resistant 129 strain with a targeted deletion of the Klrg1
gene. This strongly suggests that CD94 cannot be replaced by
other NK cell receptors and that it is absolutely essential for
the resistance of wild-type mice B6 to mousepox.
Consistent with a role for CD94 in the recognition of ECTV
infection byNK cells, mice deficient in CD94 succumbed at times
similar to those of NK cell-depleted mice (Fang et al., 2008;
Parker et al., 2007) and, when compared with wild-type B6
mice, had significantly increased virus loads in liver 3 dpi,
a time point when NK cells, but not T cells, play an important
role in controlling virus spread from the D-LN (Fang et al.,
2008). Thus, although CD94-deficient mice had a very dimin-
ished CD8+ T cell response, this was the consequence, rather
than the primary reason, for the lack of virus control as we previ-
ously demonstrated for NK cell-depleted mice (Fang et al., 2008)
andmore recently for aged B6mice (Fang et al., 2010). It remains
possible, however, that CD94 on cells other than NK cells might
also have contributed to protection.
Our study also revealed that ECTV-infected cells are specif-
ically recognized by the activating receptor formed by CD94
and NKG2E and that this recognition requires the expression
of the nonclassical MHC class I molecule Qa-1b at the surface
of ECTV-infected cells. Moreover, at the peak of the NK cell
response in the D-LN, the proportion of NK cells expressing
CD94 paired to activating NKG2s increased at the expense
of those expressing inhibitory CD94-NKG2A receptors. In
addition, ECTV infection upregulated Qa-1b expression in cells.
An important remaining question will be to understand how NK
cells switch from the inhibitory CD94-NKG2A to the activating
CD94-NKG2E receptor. NK cells do not proliferate in the D-LN
3 dpi (Fang et al., 2008). Thus, the most likely explanations are
a change in the cellular expression of the different NKG2s as
a consequence of activation or the preferential recruitment of
cells expressing activating NKG2s into the D-LN.
Similar to class Ia MHC molecules, Qa-1b binds short
peptides; however, most Qa-1b molecules are normally occu-
pied by AMAPRTLLL (Aldrich et al., 1994), a peptide derived
from the signal peptide of class Ia MHC I molecules (Aldrich
et al., 1994; DeCloux et al., 1997). It appears that recognition586 Immunity 34, 579–589, April 22, 2011 ª2011 Elsevier Inc.of Qa1b by CD94-NKG2E is insufficient to trigger activation
because the NFAT-GFP reporter cells expressing CD94-
NKG2E receptors were not stimulated unless the target cells
were infected with ECTV. It seems more probable that infection
also results in the presentation of novel peptide(s) by Qa-1b
(either a viral peptide or a peptide derived from an infection-
induced cellular protein), resulting in Qa-1b-peptide complexes
with higher affinity for CD94-NKG2E.
Wepreviously reported that NKG2D is required for the ability of
NK cells to protect from mousepox infection (Fang et al., 2008).
We have also shown that ECTV upregulates expression of
NKG2D ligands on infected cells and that resistance to mouse-
pox infection is diminished by blocking the NKG2D receptor
in vivo (Fang et al., 2008). Our present findings with reporter
assays, as well as in vitro stimulation of primary NK cells with
mAbs, suggest that CD94-NKG2E and NKG2D synergize to
achieveoptimalNKcell activation tomount aprotective response
against ECTV, which is consistent with the dual requirement for
NKG2D and CD94 for resistance to mousepox. Although the
molecular mechanism for this synergy remains unexplained, we
speculate that stimulation through both receptors is required to
overcome the inhibitory effects of NKG2A or other inhibitory
receptors or, most likely, that the presence of both receptors at
the immune synapse favor a stronger activating signal through
the recruitment of DAP12. There is strong precedent for synergy
between NKG2D and other activating receptors such as with KIR
in human NK cells (Wu et al., 2000) or with the T cell receptor in
humans (Groh et al., 2001) and mice (Jamieson et al., 2002).
Many of the activating NK receptors in the Ly49 and KIR fami-
lies, as well as human CD94-NKG2C, have low to undetectable
affinity for MHC class I. We speculate that the mouse CD94-
NKG2E might have a low affinity for Qa-1b expressed on normal,
healthy cells to avoid autoimmunity, but that peptides derived
from ECTV-infected cells might generate higher-affinity Qa-1b
ligands. Further, we hypothesize that because of the low affinity
of the CD94-NKG2E receptor, productive activation might
require synergistic signals derived from the NKG2D receptors.
In light of our findings, we propose a model whereby NK cells,
probably activated through cytokines, migrate to the D-LN and
kill ECTV-infected cells via CD94-NKG2E for specific recognition
of targets expressing a specific peptide(s) bound to Qa-1b, and
NKG2Dasacostimulator (Fanget al., 2008). Thismodel is consis-
tent with the current view that activating receptors are not essen-
tial for the cytokine-induced activation of the NK cells during
a viral infection but are required for the cytolysis of the virus-
infected target cells (Lee and Biron, 2010; Vance et al., 1998).
Importantly, different from the recognition of MCMV by Ly49-
activating receptors, the CD94-NKG2 system is exquisitely
conserved between rodents and primates (Vance et al., 1999)
and the sequences of all OPVs are also highly conserved. This
suggests that the recognition of OPVs by NK cells might be
conserved between humans and mice and relevant in protection
against smallpox and monkeypox infection.EXPERIMENTAL PROCEDURES
Tissue Culture
The dendritic cell line DC2.4 (Shen et al., 1997) was a gift from K. Rock (Univer-
sity of Massachusetts Medical Center, Worcester, MA). As L cells, we used
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from the C3H/An mouse strain stably transfected with T7 polymerase (a kind
gift from B. Moss, NIAID, MD). BS-C-1 cells (ATCC #CCL-26) were a gift
from G. Cohen (University of Pennsylvania, Philadelphia, PA). 293T cells
(ATCC #CRL-11268) were purchased from ATCC. Reporter cells were Ba/F3
cells transfected with a NFAT-inducible GFP construct (Hooijberg et al.,
2000), Flag-tagged mouse DAP12 for signal transduction, HA-tagged mouse
CD94, myc-tagged mouse NKG2C or NKG2E, and/or mouse NKG2D-S.
For cell culture, we used RPMI 10, which consisted of RPMI-1640 tissue
culture medium (Invitrogen Life Technologies) supplemented with 10% FCS
(Sigma-Aldrich), 100 IU/ml penicillin and 100 mg/ml streptomycin (Invitrogen
Life Technologies), 10 mM HEPES buffer (Invitrogen Life Technologies), and
0.05mM2-ME (Sigma-Aldrich). For virus growth and titers, RPMI 2.5 (as above
but with 2.5% FCS) was used. When required, 10 U/ml recombinant mouse
interleukin-2 (IL-2) (BD) was added to RPMI 10 (RPMI 10-IL2). All cells were
grown at 37C with 5% CO2.
Viruses
Initial stocks of the WT ECTV Moscow were obtained from ATCC (#VR-1374).
New stocks of ECTV were expanded in BSC-1 cells infected with 0.1 plaque-
forming units/cell (PFU/cell). Titers in stocks were determined by plaque
assays on confluent BSC-1 cells via 10-fold serial dilutions of the stocks in
0.5 ml RPMI 2.5 in 6-well plates (2 wells/dilution) for 1 hr. Two ml fresh RPMI
2.5 was added and the cells incubated at 37C for 5 days. Next, the media
was aspirated and the cells fixed and stained for 10minwith 0.1%crystal violet
in 20% ethanol. The fix and stain solution was subsequently aspirated, the
cells air-dried, the plaques counted, and the PFU/ml in stocks were calculated
accordingly.
For the determination of virus titers in spleens or LNs, the organs were
removed from experimental mice at indicated days after footpad infection,
made into a single-cell suspension between two frosted slides, and resus-
pended in 10 ml RPMI 10 medium. One ml of the cell suspensions were frozen
and thawed three times and titers determined in 10-fold serial dilutions of the
cell lysates as above. Virus titers were calculated as PFU/spleen or PFU/LN. To
determine the virus titers in liver, a portion of the liver wasweighed and homog-
enized in medium by means of a Tissue Lyser (QIAGEN). The virus titers were
calculated as PFU/100 mg liver.
Mice
The Fox Chase Cancer Center Institutional Animal Care and Use Committee
approved the experimental protocols involving animals. B6 mice were
purchased from Taconic when theywere 8–10weeks of age and rested at least
a week before use in experiments. The B6.D2-D6mice were initially purchased
from Jackson Laboratory and bred in the Fox ChaseCancer Center Laboratory
Animal Facility. The CD69-deficient mice (Murata et al., 2003), which were
generated via 129 strain ES cells and backcrossed to C57BL/6, were a kind
gift from J. Cyster (University of California San Francisco, San Francisco,
CA). CD94-deficient and CD94-transgenic mice were made as described
(Orr et al., 2010) and bred in the Fox Chase Cancer Center Laboratory Animal
Facility. The CD94 transgenic mice were crossed with CD94-deficient mice or
B6.D2-D6 mice. The F2 generation was genotyped by PCR with tail DNA with
a forward primer for exon 3 (CTGAATGCTGTGTTTGCCTGGACAA) and
a reverse primer for exon 6 (TCACAGGATTCAGCAGAAACGCTTTTG) that
amplify a 334 bp fragment from cDNA and a 3010 bp fragment from the
genomic Klrd1 gene. The F2 mice were also analyzed by flow cytometry after
staining with NK1.1 (PK136) and CD94 (18d3) mAbs. Pure lines were estab-
lished by intercrossing NK1.1CD94+ animals. B6129S6-H2T3 (Qa-1b-defi-
cient) mice were purchased from Jackson Laboratory.
Infections
Mice were infected in the left footpad with 25 ml PBS containing 3 3 103 PFU
ECTV. After infections, mice were observed daily for signs of disease (lethargy,
ruffled hair, weight loss, skin rash, eye secretions). When death was consid-
ered imminent (unresponsiveness to touch, lack of voluntary movements)
the mice were euthanized and recorded as dead. Adoptive transfer of memory
CD8+ T cells was exactly as before, but with CD8+ T cells purified from VACV-
immune CD94-deficient mice instead of BALB/c mice (Xu et al., 2007).A9T7 cells (5 3 106) were plated in 6-well plates and cultured overnight
to allow cells to adhere. The cells were then infected with 1 PFU ECTV/cell
for 4 hr, collected, washed, stained, and analyzed for surface expression of
Qa-1b.
In Vivo Depletion of NK Cells and NKG2 Blockade
Depletion of NK cells in B6 mice was performed by intraperitoneal (i.p.) inocu-
lation of 200 mg NK1.1 mAb PK136 or 15 ml Asialo GM1 antisera (Wako
Chemicals) 1 day before infection, as previously described (Fang et al.,
2008). For in vivo blockade of the CD94-NKG2 receptors, mice were inocu-
lated i.p. with 150 mg of the neutralizing, nondepleting 20D5HCmIgG1-Q
mAb 1 day before infection. The production of neutralizing, nondepleting
20D5HCmIgG1 mAb that binds to NKG2A, NKG2C, and NKG2E has been
described previously (Orr et al., 2010).
Flow Cytometry
Detection of NK and T cell responses was performed as described previously
(Fang et al., 2008; Fang and Sigal, 2005, 2006, 2010). In brief, for T cell
responses, lymphocytes were obtained from mice at different dpi and made
into single-cell suspensions. After osmotic lysis of red blood cells with
0.84% NH4Cl, cells were washed and 10
6 cells were cultured at 37C in
96-well plates in the presence of 2 3 105 VACV-infected DC2.4 cells or unin-
fected DC2.4 cells as control (stimulation with VACV- or ECTV-infected
DC2.4 cells produces similar results when measuring anti-ECTV responses).
For simplicity, we restimulated with VACV in all experiments. After 5 hr, Brefel-
din A (BFA, Sigma) was added to block the secretory pathway and allow for the
accumulation of cytokines inside the cells. After an additional 1.5 hr incubation,
2.4G2 mAb (anti-CD16 + CD32, ATCC) was added to block nonspecific
binding of fluorochrome-conjugated mAbs to Fc receptors. The cells were
then stained for cell surface molecules, fixed, permeabilized, and stained for
intracellular molecules with the Cytofix/Cytoperm kit (Becton Dickinson, BD)
according to the manufacturer’s instructions. To determine NK cell responses
in LNs, intact organswere incubated at 37C for 1 hr inmedia containing 10 mg/
ml Brefeldin A, made into single-cell suspensions, stained, and analyzed as
described above. For the determination of proliferation by BrdU incorporation
5 dpi, mice were injected i.p. with 2mg BrdU in sterile PBS and euthanized 3 hr
later. Staining was exactly as described previously (Fang et al., 2008). The
following mAb and staining reagents were used: anti-CD8a (53-6.7, BD),
anti-CD3e (145-2C11, BD), anti-NKp46 (29A1.4), anti-CD94 (18D3), anti-
NKG2 (20D5, eBioscience), anti-NKG2AB6 (16A11, eBioscience), anti-DX5
(DX5), anti-NK1.1 (PK136, BD), anti-IFN-g (XMG1.2, BD), anti-Qa-1b
(6A8.6F10.1A6, BD), anti-CD11b (M1/70, eBioscience), anti-CD27 (LG 3A10,
BD), anti-NKG2D (C7, BD), anti-BrdU (eBioscience), and anti-human GzB
(GzB, Caltag) that cross-reacts with mouse GzB (48). For TSYKFESV specific
CD8+ T cell H2-Kb:Ig recombinant fusion protein (Dimer-X, BD) were incubated
with synthetic TSYKFESV peptide (genScript) and used as recommended by
the manufacturer. Stained cells were analyzed by flow cytometry at the Fox
Chase Cell Sorting Facility with a LSR II system (BD).
Reporter Cell Assays
When A9T7 cells were used for restimulation, 43 105 A9T7 cells were plated in
24-well plates and cultured overnight to allow cells to adhere. The cells were
then infected with 1 PFU ECTV/cell or left uninfected for 2 hr and washed,
and 2 3 105 of the indicated NFAT-GFP reporter cells were added to the
well and incubated for 18 hr. The reporter cells were washed and analyzed
for expression of GFP by flow cytometry. For mAb blockade, the reporter cells
were added to the indicated well in the presence of 20 mg/ml CD94mAb (clone
18D3).
When 293T cells were used for restimulation, 2.4 3 104 cells were plated
in 96-well plates and cultured overnight to allow cells to adhere. The cells
were then transfected with 0.1 mg pCDNA3.1-Qa-1 (a gift from J. Forman,
University of Texas Southwest Medical Center, Dallas, TX) with TransIT-LT1
reagent (Mirus) according to the manufacturer’s instructions. The next day,
some wells were infected with 1 PFU ECTV/cell for 2 hr and washed, and
2 3 104 reporter cells were added to the well and then incubated for 18 hr.
The reporter cells were washed and analyzed for expression of GFP by
flow cytometry.Immunity 34, 579–589, April 22, 2011 ª2011 Elsevier Inc. 587
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Flat-bottom, high protein-binding plates (Thermos Fisher Scientific) were
coated with NKG2D mAb CX5 (1.0 mg/ml) and/or anti-NKG2 Ab 20D5
(2.5 mg/ml), NKG2AB6mAb 16A11 (2.5 mg/ml) at 4C overnight. After extensive
washing, B6 splenocytes (106/well) in RPMI 10 containing 10 mg/ml brefeldin A
and 1000 U/ml recombinant human IL-2 (Roche, Basel, Switzerland; from the
NCI Biological Resources Branch, Frederick, MD) were added to triplicate
wells. Cells were incubated for 5 hr at 37C, stained for surface cell markers
and intracellular IFN-g, and analyzed by flow cytometry.
Quantitative Real-Time PCR
Primers and probes for NKG2E transcripts (Mm00650941_m1*) and GAPDH
were purchased from Applied Biosystems. Total RNA was extracted from
popliteal LNs of naive or ECTV-infected mice (2 dpi). In some cases, pools
of LN cells from uninfected mice were sorted into DX5+ (NK cells) and DX5
(non-NK cells) with a mini-Macs separation unit, MS columns, and anti-DX5
MACS beads according to manufacturer’s instructions (Miltenyi Biotech).
The first-strand cDNA was synthesized with random primers. qRT-PCR was
carried out with the ABI 7500 (Applied Biosystems). The cycling conditions
for real-time PCR were 50C for 10 min, followed by 45 cycles of 95C for
30 s and 60C for 2 min. Data were analyzed with the Sequence Detection
v1.2 Analysis Software (Applied Biosystems).
Statistical Analysis
Unless indicated, all displayed data correspond to one representative experi-
ment of at least three similar experiments with groups of three to five mice.
Statistical analysis was performed with Excel or Graph Pad Prism software.
For survival studies, p values were obtained with the Log-rank (Mantel-Cox)
Test. All other statistical analyses were performed with unpaired two-tailed t
test. When applicable, data are displayed with mean ± standard error of the
mean (SEM).SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and can be found with this
article online at doi:10.1016/j.immuni.2011.02.015.
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